Posted in | News | Laser | Medical Optics

Imaging Diagnostic Systems Showcases its CTLM System at RSNA 2009

Imaging Diagnostic Systems, Inc., (OTCBB:IMDS), a pioneer in laser optical breast imaging, announced today that it is exhibiting its CTLM system and clinical case studies at the 95th annual meeting of the Radiological Society of North America (RSNA) 2009, November 29th – December 3rd in Chicago, Illinois. The company will be located at booth #7004 in Hall B of the North Building.

“With the current revision of the United States Preventive Services Task Force guidelines for breast cancer screening, it has become even more important for the company to continue to take part in the scientific dialogue at meetings such as RSNA in order to emphasize the ability of CTLM to detect mammographically occult breast cancers in women classified with dense breast and the potentially very significant future role of CTLM as a screening modality also for women under the age of 50.. ,” stated Karsten Damgaard-Iversen, IDSI/Managment Consultant to the board of directors.

According to the RSNA Daily Bulletin, attendance for the 95th annual scientific assembly, meeting, and technical exhibition is expected to be between 57,000 and 60,000, the highest number of registered professionals ever. The Technical Exhibition at the RSNA annual meeting will welcome nearly 600 of the leading international healthcare companies, remaining the top healthcare exhibition in the U.S.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.